Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 15/20 | 0.72 |
| ▸ | CA1 | P00915 | 15/20 | 0.72 |
| ▸ | CA2 | P00918 | 15/20 | 0.72 |
| ▸ | CA4 | P22748 | 15/20 | 0.72 |
| ▸ | CA9 | Q16790 | 15/20 | 0.72 |
| ▸ | PTGER2 | P43116 | 2/20 | 0.54 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.54 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.54 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5046385 | 0.92 | CA12 (0.61) | CA12CA1CA2CA4CA9 | |
| SCHEMBL13399074 | 0.92 | CA12 (0.61) | CA12CA1CA2CA4CA9 | |
| SCHEMBL5049462 | 0.90 | CA12 (0.61) | CA12CA1CA2CA4CA9 | |
| SCHEMBL5043571 | 0.88 | CA12 (0.56) | CA12CA1CA2CA4CA9 | |
| SCHEMBL4947305 | 0.87 | CA12 (0.75) | CA12CA1CA2CA4CA9 | |
| SCHEMBL5050274 | 0.87 | CA12 (0.58) | CA12CA1CA2CA4CA9 | |
| SCHEMBL5046519 | 0.86 | CA12 (0.53) | CA12CA1CA2CA4CA9 | |
| SCHEMBL27490480 | 0.86 | CXCR3 (0.60) | CA12CA1CA2CA4CA9 | |
| SCHEMBL5050517 | 0.85 | PTGER2 (0.56) | CA12CA1CA2CA4CA9 | |
| SCHEMBL5046908 | 0.85 | CA12 (0.52) | CA12CA1CA2CA4CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1021410-B1 | PROSTAGLANDIN AGONISTS AND THEIR USE TO TREAT BONE DISORDERS | PFIZER (US) | 2006-12-27 | — | — | EP | claimed |
| EP-1021410-A1 | PROSTAGLANDIN AGONISTS AND THEIR USE TO TREAT BONE DISORDERS | PFIZER INC. (US) | 2000-07-26 | — | — | EP | claimed |
| WO-1999019300-A1 | PROSTAGLANDIN AGONISTS AND THEIR USE TO TREAT BONE DISORDERS | PFIZER INC. (US) | 1999-04-22 | — | — | WO | claimed |
| US-7442702-B2 | Treatment of bone disorders; carboxy derivatives | PFIZER INC. (US) | 2008-10-28 | — | — | US | disclosed |
| EP-1021410-B1 | PROSTAGLANDIN AGONISTS AND THEIR USE TO TREAT BONE DISORDERS | PFIZER (US) | 2006-12-27 | — | — | EP | disclosed |
| US-6498172-B1 | (3-(((4-TERT-BUTYL-BENZYL)-(PYRIDINE-3-SULFONYL)-AMINO)-METHYL) -PHENOXY)-ACETIC ACID OR SALT; TREATING SUCH AS OSTEOPOROSIS | PFIZER INC. | 2002-12-24 | — | — | US | disclosed |